1[1]Xiang R,Sillettis,Lode HN,et al.Protestive immuneity against human carcinoembryonic antigen(CEA) induced by an oral DNA vaccine in CEA-transgenic mice.Clin Cancer Res,2001,7(3):856s-864s 被引量:1
2[2]Gerard CM,Baudson N,kraemerk,et al.Recombinant human paparllomavirus typel6 E7 protein as a model antigen to study the vaccine protential in control and E7 transgenic mice.Clin Canaer Res,2001,7(3):838s-847s 被引量:1
3[3]Rakhmilevich AL,imboden M,Haoz,et al.Effective particle-mediated vaccinaton against mouse melanoma by coadministration of plasmid DNA encoding gploo and granulocyte-macrophage colonystimulating factor.Clin Cancer Res,2001,7(4):952-961 被引量:1
4[4]Bail,Feuerer M,Beckhove P,et al.Generation of dendritic cells from human bone marrow mononuclear cells;advantages for clinieal ap plication in comparision to peripheral blood monocyte deprived cells.J into Oncol,2002,20(2):247-253 被引量:1
5[5]Gong J,Avigan D,chen D,et al,Activation of antitumor cytotxic T lympocytes by fusionof human dendritic cells and breast carcino ma cells.Proc Natl,Acad sic USA,2000,97(6):2715 被引量:1
7[7]Carr A.Rodriguez E,Arango Mdel C et al.Immunotheray of advanced breast cancer with a heterphilic ganglioside(NeuGe GM3)cancer.J Clin Oncol,2003,21(6):1015-1012 被引量:1
二级参考文献10
1Taylor-Papadimitriou J, Burchell J, Miles DW, et al. MUC1 and cancer [J]. Biochim Bionhvs Acta,1999, 1455: 301-313. 被引量:1
2Samuel J, Budzynski WA, Reddish MA, et al. Immunogenicity and antitumour activity of a liposomal MUC1 peptide based vaccine[J]. Int J Cancer, 1995, 75: 295-302. 被引量:1
3Karanikas V, Hwang LA, Pearson J, et al. Antibody and T cell responses of patients with adenocareinoma immunised with mannan MUC1 fusion protein [J]. J Clin Invest, 1997, 100 (11) : 2738-2792. 被引量:1
4Gilewski T, Adluri S, Ragupathi G, et al. Vaeccination of high-risk breast cancer patients with mucin-1 keyhole limpet hemocyanin conjugate plus QS-21 [J]. Clin Cancer Res, 2000, 5: 1693-1701. 被引量:1
5Takahashi T, Makiguehi Y, Hinoda Y, et al. Expression of MUC1 on myeloma cells and induction of HLA-unrestrieted CTL against MUC1 from a multiple myeloma patient [ J]. J Immunol, 1994,153 : 2102-2109. 被引量:1
6Apostolopoulos V, Karanikas V, Haurum JS, et al. Induction of HLA-A2 restricted CTLs to the mucin 1 human breast cancer antigen [J]. J Immunol, 1997, 159: 5211- 5218. 被引量:1
7Wei YQ. Immunotherapy of tumor with vaccines based on xenogeneious homologous molecules [ J]. Anticancer Drugs, 2002, 13( 3 ) : 229-235. 被引量:1
8Melina SM, Mehta V, Finn OJ. Three different vaccines based on the 140-amino acid MUClpeptide with seven tandemly repeated tumor specific epitopes elicit distinct immune effector mechanisms in wildetype versusMUCl-transgenic mice with different potential for tumor rejection [J]. J Immunol, 2001, 18: 6555..6563. 被引量:1